Kit Aids in Monitoring TKI Therapy
Measuring BCR-ABL1 transcript levels in patients with chronic myeloid leukemia, the kit monitors the effectiveness of tyrosine kinase inhibitor therapy for early detection of patient relapse.
Read MorePosted by Elaine Sanchez Wilson | Sep 4, 2015 | Cancer |
Measuring BCR-ABL1 transcript levels in patients with chronic myeloid leukemia, the kit monitors the effectiveness of tyrosine kinase inhibitor therapy for early detection of patient relapse.
Read MorePosted by Elaine Sanchez Wilson | Aug 30, 2015 | Cancer, Molecular Diagnostics |
An indispensable component of personalized medicine, companion diagnostics are certain to increase in the breadth of their application to disease areas.
Read MorePosted by Steve Halasey | Jul 28, 2015 | Infectious Diseases |
New test for the Roche serology assay portfolio helps specialists to identify HTLV-I/II infection in donated blood and diagnostic samples.
Read MorePosted by Elaine Sanchez Wilson | May 8, 2015 | Cancer, Colorectal, Molecular Diagnostics |
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read MorePosted by Steve Halasey | Jan 15, 2015 | Cancer, Leukemia, Melanoma, Molecular Diagnostics, Research, Unknown Origin & Other Cancer Types |
After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read More